Effects of Cannabidiol‐Rich Cannabis Oil on Facial Expression Recognition and Theory of Mind in Children With Autism Spectrum Disorder: A Randomized Clinical Trial
Authors:
- Katy Lísias Gondim Dias de AlbuquerqueKAKaty Lísias Gondim Dias de Albuquerque
- Marine Diniz da RosaMRMarine Diniz da Rosa
- Maycon Jônatas da SilvaMSMaycon Jônatas da Silva
- João Vitor Andrade FernandesJFJoão Vitor Andrade Fernandes
- Ana Hermínia Andrade e SilvaASAna Hermínia Andrade e Silva
- Carlos Espínola Neto SegundoCSCarlos Espínola Neto Segundo
Open Access
- 26 August 2026
- journal article
- research article
- Published by Wiley in Autism Research
- Vol. 19 (10) , e70353
Abstract
To evaluate, in a post hoc subanalysis, the effects of cannabidiol (CBD)‐rich cannabis oil on facial expression recognition and theory of mind in children with autism spectrum disorder (ASD). This post hoc subanalysis included children from a double‐blind, randomized, placebo‐controlled trial who completed social cognition assessments at baseline and after treatment. Participants received CBD‐rich cannabis oil or placebo for 12 weeks. Facial expression recognition and theory of mind were assessed using neuropsychological tasks. Between‐group differences were evaluated using the Mann–Whitney U test, whereas within‐group changes were assessed using the Wilcoxon signed‐rank test. Nineteen Brazilian children with ASD were included (72.7% male; mean age, 7.82 years). Within‐group analyses showed significant improvements in facial expression recognition ( p = 0.030) and verbal theory of mind ( p = 0.016) after treatment in the CBD group, whereas corresponding changes in the placebo group were not statistically significant. However, between‐group comparisons showed no significant differences after treatment in facial expression recognition ( p = 0.527) or verbal theory of mind ( p = 0.901). Total theory of mind scores improved significantly within both groups, with no significant between‐group difference ( p = 0.967). Although significant within‐group improvements in facial expression recognition and verbal theory of mind were observed following CBD‐rich cannabis oil treatment, these changes were not significantly different from those observed with placebo. Given the small sample size and exploratory post hoc design, these findings should be interpreted cautiously and do not establish a treatment effect of CBD on social cognition in children with ASD. Trial Registration: Brazilian Clinical Trials Registry (ReBEC), RBR‐5wr2cqq (UTN: U1111‐1261‐4178), accessible at https://ensaiosclinicos.gov.br/rg/RBR‐5wr2cqqKeywords
Funding Information
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
This publication has 22 references indexed in Scilit:
- The Effects of Cannabidiol and δ-9-Tetrahydrocannabinol in Social Cognition: A Naturalistic Controlled StudyCannabis & Cannabinoid Research, 2024
- Autism Spectrum DisorderJAMA, 2023
- Reexamining empathy in autism: Empathic disequilibrium as a novel predictor of autism diagnosis and autistic traitsAutism Research, 2022
- Face perception predicts affective theory of mind in autism spectrum disorder but not schizophrenia or typical development.Journal of Abnormal Psychology, 2021
- The effects of Cannabidiol (CBD) and Delta-9-Tetrahydrocannabinol (THC) on the recognition of emotions in facial expressions: A systematic review of randomized controlled trialsNeuroscience & Biobehavioral Reviews, 2020
- A quantitative meta-analysis of face recognition deficits in autism: 40 years of research.Psychological Bulletin, 2020
- Endocannabinoid Signaling in the Control of Social BehaviorTrends in Neurosciences, 2017
- Acute effects of delta-9-tetrahydrocannabinol, cannabidiol and their combination on facial emotion recognition: A randomised, double-blind, placebo-controlled study in cannabis usersEuropean Neuropsychopharmacology, 2015
- Modulation of effective connectivity during emotional processing by Δ9-tetrahydrocannabinol and cannabidiolInternational Journal of Neuropsychopharmacology, 2009
- Cannabinoids and neuroinflammationBritish Journal of Pharmacology, 2004